Contact:
Lab: 2224.02.125
Office: 2224.02.135
Phone: 39-23873
Research Topic:
Supramolecular peptide-glycopeptide conjugate vaccines
Curriculum Vitae:
07/2020 - 02/2021 | Postdoctoral researcher in the group of Prof. Pol Besenius, JGU Mainz |
11/2019 - 03/2020 | Research Assistant in the groups of Dr. Andrew Flaus & Professor Paul V. Murphy, Centre for Chromosome Biology, National University of Ireland Galway, Galway, Ireland |
07/2019 - 08/2019 | Postgraduate internship in the group of Prof. Jesús Jiménez-Barbero, CIC bioGUNE, Derio, Spain |
01/2018 - 12/2018 | Predoctoral research fellow in the group of Prof. Jerome Groopman, supervision by Dr. Gabriel Birrane, Harvard Medical School, Experimental Medicine, BIDMC X Ray Core, Boston, MA, USA |
10/2017 - 11/2017 | Postgraduate internship in the group of Prof. Ulrika Westerlind, ISAS, Dortmund, Germany |
2015 - 2019 | Ph.D. Candidate in chemistry, National University of Ireland Galway, Galway, Ireland |
06/2015 - 09/2015 | Research Assistant in the group of Prof. Paul V. Murphy, National University of Ireland Galway, Galway, Ireland |
01/2015 - 06/2015 | Postgraduate placement in the group of Prof. Andreas Kirschning, Leibniz University, Hannover, Germany |
2014 | Master thesis in the group of Prof. Gianluigi Broggini, supervision professor Daniele Passarella, University of Insubria, Como, Italy |
04/2014 - 07/2014 | Graduate internship in the group of Prof. Paul V. Murphy, National University of Ireland Galway, Galway, Ireland |
2012 - 2014 | Master of Science in Chemistry, University of Insubria, Como, Italy |
2012 | Bachelor thesis in the group of Prof. Gianluigi Broggini, University of Insubria, Como, Italy |
2010 - 2015 | Laboratory internship, University of Insubria, Como, Italy |
2009 - 2012 | Bachelor of Science in chemistry and industrial chemistry, University of Insubria, Como, Italy |
2009 | Baccalaureate in educational science, Liceo Vittorio Sereni, Luino, Italy |
Publications:
[12] MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-Type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.A. Gabba*, R. Attariya, S. Behren, C. Pett, J.C. van der Horst, H. Yurugi, J. Yu, M. Urschbach, J. Sabin, G. Birrane, E. Schmitt, S.J. van Vliet‡, P. Besenius‡, U. Westerlind‡, P.V. Murphy‡,
J. Am. Chem. Soc. 2023, 24, 13027-13037. DOI: 10.1021/jacs.2c12843.
(§ joint senior authors) [11] Exploring the Galectin Network by Light and Fluorescence Microscopy.
G.G. Caballero, J.C. Manning, A. Gabba, D.M. Beckwith, F.G. FitzGerald, T.J. Kutzner, A.-K. Ludwig, H. Kaltner, P.V. Murphy, M. Cudic, H.-J. Gabius,
Methods Mol. Biol. 2022, 2442, 307–338. DOI: 10.1007/978-1-0716-2055-7_17. [10] The Development of Vaccines from Synthetic Tumor-Associated Mucin Glycopeptides and their Glycosylation-Dependent Immune Response.
N. Stergiou*, M. Urschbach, A. Gabba, E. Schmitt, H. Kunz, P. Besenius*,
Chem. Rec. 2021, 21, 3313-3331. DOI: 10.1002/tcr.202100182. [9] Imitating evolution’s tinkering by protein engineering reveals extension of human galectin-7 activity.
A.-K. Ludwig, M. Michalak, A. Gabba, T.J. Kutzner, D.M. Beckwith, F.G. FitzGerald, G.G. Caballero, J.C. Manning, M. Kriegsmann, H. Kaltner, P.V. Murphy, M. Cudic, J. Kopitz, H.-J. Gabius,
Histochem. Cell Biol. 2021,156, 253–272. DOI: 10.1007/s00418-021-02004-w. [8] Probing sulfatide-tissue lectin recognition with functionalized glycodendrimersomes.
P.V. Murphy, A. Romero, Q. Xiao, A.-K. Ludwig, S. Jogula, N.V. Shilova, T. Singh, A. Gabba, B. Javed, D. Zhang, F.J. Medrano, H. Kaltner, J. Kopitz, N.V. Bovin, A.M. Wu, M.L. Klein, V. Percec, H.-J. Gabius,
iScience 2021, 24, 101919. DOI: 10.1016/j.isci.2020.101919. [7] Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen.
A. Gabba, A. Bogucka, J. G. Luz, A. Diniz, H. Coelho, F. Corzana, F. J. Cañada, F. Marcelo, P. V. Murphy, G. Birrane,
Biochemistry 2021, 60, 1327–1336. DOI: 10.1021/acs.biochem.1c00009. [6] Influence of protein (human galectin-3) design on aspects of lectin activity.
G. G. Caballero, D. Beckwith, N. V. Shilova, A. Gabba, T. J. Kutzner, A. Ludwig, J. C. Manning, H. Kaltner, F. Sinowatz, M. Cudic, N.V. Bovin, P. V. Murphy, H. J. Gabius,
Histochem. Cell Biol. 2020,154, 135–153. DOI: 10.1007/s00418-020-01859-9. [5] How altering the modular architecture affects lectin activity: case study on human galectin-1.
T. J. Kutzner *, A. Gabba*, F. G. FitzGerald*, N. V. Shilova*, G. G. Caballero, A. Ludwig, J. C. Manning, C. Knospe, H. Kaltner, F. Sinowatz, P. V. Murphy, M. Cudic, N. V. Bovin, H. J. Gabius,
Glycobiology 2019, 29, 593-607. DOI: 10.1093/glycob/cwz034. [4] Revealing biomedically relevant cell and lectin type-dependent structure-activity profiles for glycoclusters by using tissue sections as assay platform.
H. Kaltner, J. C. Manning, G. G. Caballero, C. Di Salvo, A. Gabba, L. Romero, C. Knospe, D. Wu, H. Daly, D. F. O’Shea, H. J. Gabius. P. V. Murphy,
RSC Adv. 2018, 8, 28716-28735. DOI: 10.1039/c8ra05382k. [3] Anomer Preferences for Glucuronic and Galacturonic Acid and Derivatives and Influence of Electron-Withdrawing Substituents.
L. Kerins, S. Byrne, A.Gabba, P.V. Murphy,
J. Org. Chem. 2018, 83, 7714-7729. DOI: 10.1021/acs.joc.8b00610. [2] Synthesis and Biological Evaluation of Migrastatin Macrotriazoles.
A.Gabba, S. Robakiewicz, B. Tacia, K. Ulewicz, G. Broggini, G. Rastelli, M. Krol, P. V. Murphy, D. Passarella,
Eur. J. Org. Chem. 2017, 60-69. DOI: 10.1002/ejoc.201600988. [1] 1,2-Bis (diphenylphosphano) Ethane (DPPE)-Mediated Synthesis of Glycosyl Amides.
D. Temelkoff, P. Norris, A.Gabba,
Carbohydrate Chemistry Proven Synthetic Methods 2017, Vol. 4 & J. Carbohydr. Chem. 2018, 37 (3) 198-198. DOI: 10.1080/07328303.2018.1454795.